Effect of magnesium sulfate and nifedipine in preterm labor

Phase 2

• Conditions: Preterm Labor.; Preterm labor without delivery, unspecified trimester; O60.00

• Registration Number: IRCT20201017049052N1
• Lead Sponsor: Ahvaz University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 30 November 2020

Recruitment & Eligibility

• Status: Complete
• Sex: Female
• Target Recruitment: 100

Inclusion Criteria

Single fetus pregnancy
Pregnancy in 28_34 weeks of gestational age
Not in the active phase of labor
No contraindication to continue pregnancy

Exclusion Criteria

Any situation that makes it impossible to continue the pregnancy
Contraindications to the use of Nifedipin or Magnesium sulfate in the patient

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Delaying preterm delivery for more than 48 hours. Timepoint: Measurement of dilatation and effaceman of the cervix before treatment and 24 hours and 48 hours after treatment. Method of measurement: Manual vaginal examination.

Secondary Outcome Measures

Name	Time	Method
Drug side effects. Timepoint: Frequently after starting treatment until the end of the dose. Method of measurement: Patient statement and questionnaire.